Triple-Negative Breast Cancer | Hope S Rugo, MD

Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Triple-Negative Breast Cancer — Faculty Presentation 2: Novel Applications of Immune Checkpoint Inhibitors for Patients with Early TNBC — Dr Rugo. CME information and select publications